Trial Profile
TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Beraprost (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Sponsors Toray
- 01 Jul 2015 New trial record